You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 50 No. 9, September 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study

C. A. Cuenod, A. Denys, J. L. Michot, P. Jehenson, F. Forette, D. Kaplan, A. Syrota and F. Boller
Frederic-Joliot Hospital, Atomic Energy Commission, Orsay, France.

OBJECTIVES--To study the ability of magnetic resonance imaging to measure the volume of the amygdala and detect amygdala atrophy in patients with early Alzheimer's disease. DESIGN--Prospective case-control study and "blind" measurements. SETTING--Subjects were ambulatory outpatients selected from an institutional practice in Paris, France. PATIENTS--We studied 11 patients with probable Alzheimer's disease according to National Institute of Neurologic and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) and Consortium to Establish a Registry for Alzheimer's Disease (CERAD) inclusion and exclusion criteria, as well as six age-matched control subjects. INTERVENTION--None. MAIN OUTCOME MEASURE--A 1.5-T magnetic resonance imager was used to acquire the images. Two neuroradiologists independently and blindly measured the volume of the right and left amygdalas on high-resolution contiguous slices. In addition, other cerebral structures, ie, the sylvian fissures, temporal lobes, lateral and third ventricles, corpus callosum, and hippocampal formation, were measured on a single slice. RESULTS--The values obtained by the two observers correlated highly (r = .90), and interrater variability was 13%. The Alzheimer's disease group showed significant (33%, P < .0001) atrophy of the amygdala when compared with the control group. The other structures showed less variation. CONCLUSION--Significant amygdala atrophy can be detected in vivo in patients with early Alzheimer's disease by means of standard magnetic resonance imaging. This technique may be useful in the early diagnosis of Alzheimer's disease.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of Hippocampal and Amygdalar Volumes on Magnetic Resonance Imaging to Predict Dementia in Cognitively Intact Elderly People
den Heijer et al.
Arch Gen Psychiatry 2006;63:57-62.
ABSTRACT | FULL TEXT  

Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia
den Heijer et al.
Am. J. Clin. Nutr. 2004;80:992-997.
ABSTRACT | FULL TEXT  

Cinguloparietal Atrophy Distinguishes Alzheimer Disease From Semantic Dementia
Boxer et al.
Arch Neurol 2003;60:949-956.
ABSTRACT | FULL TEXT  

Higher Estrogen Levels Are Not Associated With Larger Hippocampi and Better Memory Performance
den Heijer et al.
Arch Neurol 2003;60:213-220.
ABSTRACT | FULL TEXT  

Progression of Corpus Callosum Atrophy in Alzheimer Disease
Teipel et al.
Arch Neurol 2002;59:243-248.
ABSTRACT | FULL TEXT  

Homocysteine and brain atrophy on MRI of non-demented elderly
den Heijer et al.
Brain 2002;126:170-175.
ABSTRACT | FULL TEXT  

Apolipoprotein E {epsilon}4 and the pattern of regional brain atrophy in Alzheimer's disease
Hashimoto et al.
Neurology 2001;57:1461-1466.
ABSTRACT | FULL TEXT  

Cortical Change in Alzheimer's Disease Detected with a Disease-specific Population-based Brain Atlas
Thompson et al.
Cereb Cortex 2001;11:1-16.
ABSTRACT | FULL TEXT  

Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD
Xu et al.
Neurology 2000;54:1760-1767.
ABSTRACT | FULL TEXT  

Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease: Power Calculations and Estimates of Sample Size to Detect Treatment Effects
Fox et al.
Arch Neurol 2000;57:339-344.
ABSTRACT | FULL TEXT  

Region-Specific Corpus Callosum Atrophy Correlates With the Regional Pattern of Cortical Glucose Metabolism in Alzheimer Disease
Teipel et al.
Arch Neurol 1999;56:467-473.
ABSTRACT | FULL TEXT  

Medial temporal lobe atrophy on MRI in dementia with Lewy bodies
Barber et al.
Neurology 1999;52:1153-1153.
ABSTRACT | FULL TEXT  

Corpus Callosum Atrophy Is a Possible Indicator of Region- and Cell Type-Specific Neuronal Degeneration in Alzheimer Disease: A Magnetic Resonance Imaging Analysis
Hampel et al.
Arch Neurol 1998;55:193-198.
ABSTRACT | FULL TEXT  

Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study
Mori et al.
J. Neurol. Neurosurg. Psychiatry 1997;63:214-221.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.